Cargando…

Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants

Since its emergence in China at the end of 2019, SARS-CoV-2 has rapidly spread across the world to become a global public health emergency. Since then, the pandemic has evolved with the large worldwide emergence of new variants, such as the Alpha (B.1.1.7 variant), Beta (B.1.351 variant), and Gamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lebourgeois, Samuel, Chenane, Houssem Redha, Houhou-Fidouh, Nadhira, Menidjel, Reyene, Ferré, Valentine Marie, Collin, Gilles, Benmalek, Nabil, Coppée, Romain, Larrouy, Lucile, Yazdanpanah, Yazdan, Timsit, Jean-François, Charpentier, Charlotte, Descamps, Diane, Visseaux, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716835/ https://www.ncbi.nlm.nih.gov/pubmed/34976868 http://dx.doi.org/10.3389/fcimb.2021.792202

Ejemplares similares

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Differential activation of human neutrophils by SARS-CoV-2 variants of concern
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
por: Loubet, Paul, et al.
Publicado: (2017)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021
por: Coppée, Romain, et al.
Publicado: (2022)

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016
por: Visseaux, Benoit, et al.
Publicado: (2017)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study
por: Bouzid, Donia, et al.
Publicado: (2023)

Usefulness of multiplex PCR methods and respiratory viruses’ distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study
por: Visseaux, Benoit, et al.
Publicado: (2017)

Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France
por: Charpentier, Charlotte, et al.
Publicado: (2021)

SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates
por: Farfour, E., et al.
Publicado: (2023)

Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
por: Michiels, Yves, et al.
Publicado: (2021)

Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient
por: Michiels, Yves, et al.
Publicado: (2021)

Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia
por: Voiriot, Guillaume, et al.
Publicado: (2016)

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Case report study of the first five COVID-19 patients treated with remdesivir in France
por: Dubert, Marie, et al.
Publicado: (2020)

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients
por: Charpentier, Charlotte, et al.
Publicado: (2013)

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
por: Gounant, Valérie, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Late viral or bacterial respiratory infections in lung transplanted patients: impact on respiratory function
por: Dubert, Marie, et al.
Publicado: (2020)

Focus on Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Bleibtreu, A., et al.
Publicado: (2020)

HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution
por: Visseaux, Benoit, et al.
Publicado: (2021)

Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020
por: Coppée, Romain, et al.
Publicado: (2023)

Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study
por: Mailhe, Morgane, et al.
Publicado: (2023)

Humoral Response to SARS-CoV-2 mRNA Vaccine in Heart Transplant Recipients up to 4 Months After the Third Vaccine Injection
por: Ferré, V.M., et al.
Publicado: (2022)

Multiplex PCR implementation as point-of-care testing in a French emergency department
por: Bouzid, D., et al.
Publicado: (2020)

Caractéristiques cliniques et paracliniques de 4 patients confirmés à COVID-19
por: Parisey, M., et al.
Publicado: (2020)

(61) Prevalence and Determinants of Cellular Immunity Against Sars-Cov-2 in Heart Transplant Recipients: A Cross-Sectional Study
por: Flament, H., et al.
Publicado: (2023)

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up
por: Charpentier, Charlotte, et al.
Publicado: (2015)

Faecal Viral Excretion and Gastrointestinal Co-Infection Do Not Explain Digestive Presentation in COVID-19 Patients
por: Rezzoug, Inès, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9hams6kc1kbcneih1q58bv9vfm